MC
CORZ

Moors & Cabot’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Moors & Cabot’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-39,500
Closed -$51K – 897
2022
Q3 		$51K Buy
39,500
+4,300
+12% +$9.15K ﹤0.01% 792
2022
Q2 		$52K Buy
35,200
+775
+2% +$3.56K ﹤0.01% 774
2022
Q1 		$283K Buy
+34,425
New +$304K 0.02% 645

Other funds holding CORZ

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Moors & Cabot's CORZ Position: Q4 2022 in Review

Moors & Cabot sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 39,500 shares — an estimated $51K sold.

Moors & Cabot first reported a position in CORZ in Q1 2022 and held it in 3 quarters. The position peaked at $283K in Q1 2022. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • Moors & Cabot reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Moors & Cabot sold 39,500 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $51K.
  • Moors & Cabot first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Moors & Cabot's Core Scientific, Inc. Common Stock position peaked at $283K in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on Moors & Cabot's 13F filing for Q4 2022, filed 7 Feb 2023.